Updated:
MAN Pension Trust
MAN Pension Trust was established to provide retirement benefits to staff of MAN Group, which operates in commercial vehicles and power engineering.
MAN Pension Trust
MAN Pension Trust was established to provide retirement benefits to staff of MAN Group, which operates in commercial vehicles and power engineering. The fund is administered in connection with MAN Truck & Bus and regulated by BaFin. The trust allocates across public equities valued at approximately 389 million EUR, fixed income holdings of 842 million EUR, and a real estate portfolio of 46 million EUR. It participates in early-stage venture through fund-of-funds structures and holds limited partner interests in BioGeneration Ventures Fund III and Schroder Adveq. Geographic exposure includes Germany and other European markets as well as global public securities. Confirmed holdings accessed via BioGeneration include Catalym, Scenic Biotech, VarmX, and Mellon Medical. The trust engages Willis Towers Watson as investment advisor and WTW Pensionsfonds AG as administrator. No additional offices or professional headcount figures are recorded. An operational event from 2018 shows attendance at the IAA Commercial Vehicles trade fair in Hanover. Investment decisions follow guidelines established by the TRATON SE Investment Committee, creating a direct link between the pension mandate and the commercial vehicle parent rather than an independent family or endowment structure.
General information
Firm type
Pension Fund
Location
Region
Europe
Country
Germany
City
Munich
Corporate office
Dachauer Strasse 667, Munich, Germany
Sector focus
Frequently asked questions
Who sets investment rules for MAN Pension Trust?
The TRATON SE Investment Committee establishes the investment guidelines that the trust follows (Altss research record).
Does MAN Pension Trust invest in Volkswagen Group securities?
No. The trust is prohibited from holding securities of Volkswagen Group, the ultimate parent company.
What asset classes does the trust deploy into?
Public equities, fixed income, real estate, and venture capital through fund commitments.
Which venture vehicle does the trust use for healthcare exposure?
BioGeneration Ventures Fund III, through which it holds positions in Catalym, Scenic Biotech, VarmX, and Mellon Medical.
What regulatory body oversees the trust?
BaFin, the Federal Financial Supervisory Authority of Germany.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on pension funds?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: